References
- Liu J, Yang J, Inceoglu B, et al. Inhibition of soluble epoxide hydrolase enhances the anti-inflammatory effects of aspirin and 5-lipoxygenase activation protein inhibitor in a murine model. Biochem Pharmacol 2010;79:880–7
- Chandrasekharan NV, Dai H, Lamar K, et al. COX-3, a cyclooxygenase variant inhibited by acetaminophen and other analgesic/antipyretic drugs: cloning, structure, and expression. Proc Natl Acad Sci USA 2002;99:13926–31
- Hwang SH, Wecksler AT, Wagner K, Hammock BD. Rationally designed multitarget agents against inflammation and pain. Curr Med Chem 2013;20:1783–99
- Botting RM. Inhibitors of cyclooxygenases: mechanisms, selectivity and uses. J Physiol Pharmacol 2006;57:113–24
- Mitchell JA, Akarasereenont P, Thiemermann C, et al. Selectivity of nonsteroidal antiinflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase. Proc Natl Acad Sci USA 1993;90:11693–7
- Penning TD, Tally JJ, Bertenshaw SR, et al. Synthesis and biological evaluation of the 1,5-diarylpyrazole class of cyclooxygenase-2 inhibitors: identification of 4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamide (SC-58635, celecoxib). J Med Chem 1997;40:1347–65
- Prasit P, Wang Z, Brideau C, et al. The discovery of rofecoxib, [MK 966, Vioxx, 4-(4′-methylsulfonylphenyl)-3-phenyl-2(5H)-furanone], an orally active cyclooxygenase-2-inhibitor. Bioorg Med Chem Lett 1999;9:1773–8
- Talley JA, Brown DL, Carter JS, et al. 4-[5-Methyl-3-phenylisoxazol-4-yl]-benzenesulfonamide, valdecoxib: a potent and selective inhibitor of COX-2. J Med Chem 2000;43:775–7
- Abdellatif KRA, Abdelgawad MA, Elshemy HAH, et al. Synthesis and anti-inflammatory evaluation of new 1,3,5-triaryl-4,5-dihydro-1H-pyrazole derivatives possessing an aminosulphonyl pharmacophore. Arch Pharm Res 2015;38:1932–42
- Abdellatif KRA, Elshemy HAH, Azoz AA. 1-(4-Methane(amino)sulfonylphenyl)-3-(4-substituted-phenyl)-5-(4-trifluoromethylphenyl)-1H-2-pyrazolines/pyrazoles as potential anti-inflammatory agents. Bioorg Chem 2015;63:13–23
- Abdellatif KRA, Elshemy HAH, Salama SA, Omar HA. Synthesis, characterization and biological evaluation of novel 4′-fluoro-2′-hydroxy-chalcone derivatives as antioxidant, anti-inflammatory and analgesic agents. J Enz Inhib Med Chem 2015;30:484–91
- Abdellatif KRA, Abdelall EKA, Fadaly WAA, Kamel GM. Synthesis, cyclooxygenase inhibition, and anti-inflammatory evaluation of novel diarylheterocycles with a central pyrazole, pyrazoline, or pyridine ring. Med Chem Res 2015;24:2632–44
- Abdellatif KRA, Abdelall EKA, Fadaly WAA, Kamel GM. Synthesis, cyclooxygenase inhibition, anti-inflammatory evaluation and ulcerogenic liability of new 1,3,5-triarylpyrazoline and 1,5-diarylpyrazole derivatives as selective COX-2 inhibitors. Bioorg Med Chem Lett 2016;26:406–12
- Ahlstrm K, Redderstrm M, Zamora M, Luthman I. CYP2C9 structure-metabolism relationships: optimizing the metabolic stability of COX-2 inhibitors. J Med Chem 2007;50:4444–52
- Al-Shiekh MA, Medrassi HY, Elnagdi MH, Hafez EA. Studies with 2-arylhydrazono-3-oxopropanals: routes for the synthesis of pyridazine-3,4-dicarboxylate and 3,5-diaroyl pyrazoles. Arkivok 2008;xvii:36–47
- Chanda K, Dutta M, Karim M, Vishwakarma JN. An efficient, microwave assisted solvent-free synthesis of polarized enamines. Indian Chem Soc 2004;81:791–3
- Chanda K, Dutta M, Karim M, Vishwakarma JN. A facile route to enaminones: synthesis of 3-alkyl/aralkyl/arylamino-1-arylprop-2-en-1-ones. Indian J Chem 2004;43B:2471–4
- Tseng S, Epstein JW, Brabander HJ, Francisco G. A simple regioselective synthesis of pyrimido[1,2-a]benzimidazoles. J Het Chem 1987;24:837–43
- Kalita U, Kaping S, Nongkynrith R, et al. Novel tetrahydropyrimidine-adamantane hybrids as anti-inflammatory agents: synthesis, structure and biological evaluation. Med Chem Res 2015;24:2742–55
- Jeragh B, Elassar AA. Enaminone complexes: synthesis, characterization and bioactivity. Chem Sci Trans 2015;4:113–20
- Ramarao RJ, Rao AKS, Sreenivas N, et al. Synthesis and antibacterial activity of novel 5-(heteroaryl)isoxazole derivatives. J Korean Chem Soc 2011;55:243–50
- Soliman R. Preparation and antidiabetic activity of some sulfonylurea derivatives of 3,5-disubstituted pyrazoles. J Med Chem 1979;22:321–5
- Truce WM, Vriesen E, Calvin W. Friedel–Crafts reactions of methanesulfonyl chloride with benzene and certain substituted benzenes. Am Chem Soc 1953;75:5032–6
- Pommery N, Taverrne T, Telliez A, et al. New COX-2/5-LOX inhibitors: apoptosis-inducing agents potentially useful in prostate cancer chemotherapy. J Med Chem 2004;47:6195–206
- Abdellatif KRA, Abdelwahab MA, Labib M, Zidan TH. Synthesis, cyclooxygenase inhibition, anti-inflammatory evaluation and ulcerogenic liability of novel triarylpyrazoline derivatives as selective COX-2 inhibitors. Bioorg Med Chem Lett 2015;25:5787–91
- Roschek B, Fink RC, Li D, et al. Pro-inflammatory enzymes, cyclooxygenase 1, cyclooxygenase 2, and 5-lipooxygenase, inhibited by stabilized rice bran extracts. J Med Food 2009;12:615–23
- Winter CA, Risley EA, Nuss GW. Carrageenin-induced edema in hind paw of the rat as an assay for antiiflammatory drugs. Proc Soc Exp Biol Med 1962;111:544–7
- Chowdhury MA, Abdellatif KR, Dong Y, et al. Celecoxib analogs possessing a N-(4-nitrooxybutyl)piperidin-4-yl or N-(4-nitrooxybutyl)-1,2,3,6-tetrahydropyridin-4-yl nitric oxide donor moiety: synthesis, biological evaluation and nitric oxide release studies. Bioorg Med Chem Lett 2010;20:1324–9
- Adedapo AA, Sofidiya MO, Maphosa V, et al. Antiinflammatory and analgesic activities of the aqueous extract of Cussonia Paniculatastem bark. Rec Nat Prod 2008;2:46–53